Delivery Order SPE2DR25D1053-SPE2DR26FV423
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $6,962.71 to AmerisourceBergen Drug Corp for the supply of Isotretinoin 30 mg capsules (30-count units) on January 9, 2026, with an ultimate completion date of January 12, 2026. This is a firm fixed-price, competitively awarded contract with no set-aside designation. The work will be performed at AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania. This delivery order is issued under the company's larger...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Isotretinoin 30 mg capsules (30-count) on January 6, 2026, with a contract ceiling value of $5,823.04 and an ultimate completion date of January 7, 2026. This is a firm fixed-price, non-set-aside delivery order issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at up to $999,999,999.00 and running through December 2026. The work will be...
- The Defense Logistics Agency awarded a delivery order valued at $12,289.96 to AmerisourceBergen Drug Corp for the supply of Isotretinoin 30 mg capsules (30-count units) on January 13, 2026, with completion scheduled for January 14, 2026. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc., serves as...
- The Defense Logistics Agency awarded a delivery order valued at $3,159.36 to AmerisourceBergen Drug Corp for the supply of Isotretinoin 40 mg capsules (30-count units). This firm fixed-price delivery order was competitively awarded without set-aside restrictions and is scheduled for completion by December 15, 2025. The contract represents a non-competitive delivery order issued under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a $2,521.98 delivery order on December 4, 2025, for the supply of Isotretinoin 40 mg capsules (30-count units). This is a firm fixed-price, non-set-aside contract with an ultimate completion date of December 5, 2025, and performance to be fulfilled from AmerisourceBergen's Conshohocken, Pennsylvania location. The delivery order is issued under the company's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,696.96 to AmerisourceBergen Drug Corp for Isotretinoin 30 mg capsules (10-count units) on November 17, 2025, with an ultimate completion date of November 18, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and is being performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $6,969.33 to AmerisourceBergen Drug Corp for the supply of Isotretinoin 30 mg capsules (30-count packaging) with a firm fixed price contract type. The contract was competitively awarded without a set-aside designation and is scheduled for completion by April 25, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location and deliver this pharmaceutical product to...
- The Defense Logistics Agency awarded a delivery order valued at $1,596.00 to Amerisourcebergen Drug Corp for the supply of Isotretinoin 30 mg capsules (10-count units) on January 8, 2026, with an ultimate completion date of January 9, 2026. This competitively awarded, firm fixed-price delivery order is being performed at the awardee's facility in Conshohocken, Pennsylvania, and carries no set-aside designation. Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare...
- The Defense Logistics Agency awarded a delivery order valued at $1,276.88 to AmerisourceBergen Drug Corp for the supply of Isotretinoin 30 mg capsules (30-count units) on November 10, 2025, with an ultimate completion date of November 12, 2025. This non-competitive, firm fixed-price delivery order was placed against AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $999.99 billion global pharmaceutical support vehicle designated SPE2DX and...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $9,744.67 to AmerisourceBergen Drug Corp on January 7, 2026, for the supply of Isotretinoin 40 mg capsules (30-count units). This is a firm fixed-price, non-set-aside contract with a completion date of January 8, 2026, with performance occurring at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The award is issued as a child order under AmerisourceBergen's parent company Cencora, Inc., which holds a significant...
- SPE2DR25D1053Indefinite Delivery Contract
- SPE2DR25D1053-SPE2DR26FV423Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $2,619.93 to AmerisourceBergen Drug Corp for the supply of Isotretinoin 30 mg capsules (30-count units) on January 12, 2026, with an ultimate completion date of January 13, 2026. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen Drug Corp's parent company Cencora, Inc.'s larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2031, which serves as the primary vehicle for supplying pharmaceutical products and medical supplies to support military healthcare programs globally. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, demonstrates significant capability in fulfilling federal medical procurement requirements across multiple therapeutic domains. The company's portfolio includes specialty medications, brand-name and generic drugs, vaccines, and medical devices supplied to the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. This specific delivery order for Isotretinoin, a medication used in dermatological treatment, reflects the company's continued role as a critical vendor in the military medical supply chain and represents a routine fulfillment under its comprehensive pharmaceutical prime vendor agreement with DLA.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.6k | 1/11/26 |